Hims & Hers Health, Inc.
HIMS Healthcare Drug Manufacturers Specialty & Generic
Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.
- Revenue
- +38.3%
- EPS
- −294.7%
- Free cash flow
- +5.09%
- Total debt
- +40.8%
Quarter to June 2026, against a year earlier
Follow HIMS
Alert me
Hims & Hers Health, Inc. (HIMS) Book value per share
Hims & Hers Health, Inc.'s book value per share at the end of fiscal 2025 was 2.4×, up 8.92% from 2.2× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 1.4×. Over the past ten years it has ranged from −4.2× (fiscal 2020) to 7.4× (fiscal 2019); the current reading is higher than 82% of that period. Hims & Hers Health, Inc. ranks 40th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 2.4× | 8.92% |
| FY2024 | 2.2× | 34.33% |
| FY2023 | 1.6× | 7.81% |
| FY2022 | 1.5× | 0.00% |
| FY2022 | 1.5× | (14.91%) |
| FY2021 | 1.8× | 0.00% |
| FY2021 | 1.8× | — |
| FY2020 | −4.2× | — |
| FY2020 | 2.9× | 1,927.75% |
| FY2019 | 0.1× | (98.06%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 1.4× | (28.43%) |
| Mar 2026 | 2.0× | (18.75%) |
| Dec 2025 | 2.4× | (6.32%) |
| Sep 2025 | 2.6× | 2.35% |
| 25 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| LNTH Lantheus Holdings, Inc. compare | 20.8× |
| ALKS Alkermes plc compare | 11.1× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 9.1× |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.9× |
| LQDA Liquidia Corporation compare | 2.2× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 2.2× |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 1.6× |
| HIMS Hims & Hers Health, Inc. | 1.4× |
| SUPN Indivior Pharmaceuticals Inc. compare | −0.5× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on HIMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement